imatinib mesylate has been researched along with Foot Dermatoses in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battistella, M; Dubertret, L; Frémont, G; Gornet, JM; Vignon-Pennamen, MD; Viguier, M | 1 |
| Selleslag, D | 1 |
2 other study(ies) available for imatinib mesylate and Foot Dermatoses
| Article | Year |
|---|---|
Imatinib-induced hand-foot syndrome in a patient with metastatic gastrointestinal stromal tumor.
Topics: Benzamides; Biopsy, Needle; Drug Eruptions; Erythema; Follow-Up Studies; Foot Dermatoses; Gastrointestinal Stromal Tumors; Hand Dermatoses; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Piperazines; Protein Kinase Inhibitors; Pyloric Antrum; Pyrimidines; Risk Assessment; Stomach Neoplasms; Syndrome | 2008 |
A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
Topics: Abscess; Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Foot Dermatoses; Fusarium; Humans; Imatinib Mesylate; Immunocompromised Host; Liposomes; Male; Middle Aged; Muscular Diseases; Onychomycosis; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Reoperation; Rituximab; Teniposide; Triazoles; Voriconazole | 2006 |